Noah L. Rosenberg - 24 Mar 2025 Form 3 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
CMO
Signature
/s/ Christopher Hayes, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
24 Mar 2025
Net transactions value
$0
Form type
3
Filing time
26 Mar 2025, 07:08:03 UTC
Previous filing
17 Aug 2021
Next filing
25 Nov 2025

No securities are beneficially owned.